Quantum Surgical
Quantum Surgical develops the Epione robotic-assisted percutaneous ablation platform that helps interventional radiologists treat liver, kidney, lung, and bone tumors minimally invasively. The company sells capital equipment, software, and services to hospitals and cancer centers across Europe, the US, and Asia, and now operates alongside NeuWave Medical under Precision IO Group.
- Company typePrivate
- Founded2017
- HeadquartersMontpellier, France
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Quantum Surgical does
Quantum Surgical is a French medical robotics company founded in 2017 in Montpellier that develops and commercializes the Epione robotic-assisted percutaneous ablation platform for minimally invasive cancer treatment. Epione integrates a 6-degree-of-freedom robotic arm, navigation system, camera, and AI-powered planning/confirmation software to assist interventional radiologists in performing image-guided tumor ablation across liver, kidney, lung, pancreatic, and bone indications using CT image guidance and supporting multiple energy modalities (microwave, radiofrequency, cryoablation, irreversible electroporation). The platform is CE marked for abdomen, chest, and musculoskeletal structures and FDA 510(k) cleared for abdominal ablation.
The company sells Epione as capital equipment with associated software licenses, installation/training services, and multi-year support contracts to large hospital systems and specialized cancer centers through direct enterprise field sales in Europe and the US, supplemented by a Unison Healthcare Group distribution partnership in Taiwan. Following the February 2026 acquisition of NeuWave Medical from Johnson & Johnson, Quantum Surgical and NeuWave operate as subsidiaries under newly created Precision IO Group Inc., led by CEO Kurt Azarbarzin, combining Epione's robotic platform with NeuWave's microwave ablation technology that is deployed in over 70% of top US cancer centers. Quantum Surgical has raised €40 million in Series A funding led by Ally Bridge Group plus €30 million in EIB debt financing, holds 25+ patents, and has installed Epione in 20+ cancer centers with 1,700+ patients treated worldwide.
Quantum Surgical firmographics
Firmographics- Name
- Quantum Surgical
- Legal name
- Quantum Surgical SAS
- Website
- https://quantumsurgical.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Quantum Surgical develops the Epione robotic-assisted percutaneous ablation platform that helps interventional radiologists treat liver, kidney, lung, and bone tumors minimally invasively. The company sells capital equipment, software, and services to hospitals and cancer centers across Europe, the US, and Asia, and now operates alongside NeuWave Medical under Precision IO Group.
- Ownership category
- akta.pro rank
Quantum Surgical industry classification
Industry- Product category
- Interventional Oncology / Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Electrophysiology Mapping & Ablation Systems (HLAHAFAD)
Keywords
Where Quantum Surgical is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Quantum Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Epione Robotic Platform Sales: Sale of the Epione robotic system to hospitals and cancer centers. The platform is sold as capital equipment with associated software licenses and support contracts. Installation, training, and ongoing maintenance services are provided.
- NeuWave Ablation Products: Sale of microwave ablation technology including generators, antennas, and disposables. NeuWave products are distributed in France, Germany, UK through Quantum Surgical and directly in the US market.
- Service and Support Contracts: Ongoing support, maintenance, and training services for installed base of Epione and NeuWave customers.
- Professional Services: Training, installation, and clinical support services for hospital customers implementing robotic ablation programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Direct enterprise sales to hospitals |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Quantum Surgical product offering
Product offeringCore offering
Quantum Surgical designs, manufactures, and commercializes the Epione robotic-assisted percutaneous ablation platform for interventional radiology. The system combines a robotic arm, image-guided navigation software, and ablation instrument integration to enable interventional radiologists to plan, target, and treat tumors in the abdomen and lungs via minimally invasive needle-based ablation. The company also markets the NeuWave Microwave Ablation System and the HYGIE Health Data Warehouse research infrastructure acquired through its integration into the Precision IO Group.
Product overview
Quantum Surgical offers a unified product portfolio centered on the Epione robotic-assisted percutaneous ablation platform. Epione serves as the core product—a robotic arm with navigation, planning software, and confirmation software that integrates all steps of percutaneous tumor ablation (planning, targeting, ablation, confirmation) in a single platform. The company acquired NeuWave Medical in February 2026, adding its market-leading microwave ablation system as a complementary technology used in over 70% of top US cancer centers. Both operate under Precision IO Group Inc. parent company. Epione is indicated for abdomen, chest, and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared), supporting multiple ablation modalities including microwave ablation (MWA), radiofrequency ablation (RFA), cryoablation, and irreversible electroporation (IRE).
Differentiator
Problem solved
Functional benefit
Brands
- Epione: Robotic-assisted percutaneous ablation platform for tumor treatment, indicated for abdomen, chest and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared).
- HYGIE
Products and services
- Epione Robotic-Assisted Percutaneous Ablation Platform The Epione platform is a robotic-assisted percutaneous ablation system for interventional radiologists, combining robotic needle positioning, 3D treatment planning, and image-guided navigation to plan, target, and ablate tumors in the abdomen and lungs under CT or cone-beam CT guidance. It is sold to hospitals and cancer centers performing interventional oncology procedures.
- NeuWave Microwave Ablation System The NeuWave Microwave Ablation System is a microwave ablation device used by interventional radiologists to thermally ablate soft-tissue tumors. It is sold to hospitals and interventional radiology departments, with distribution across the United States, France, Germany, and the United Kingdom.
- HYGIE Health Data Warehouse HYGIE is a clinical data warehouse and research infrastructure supporting multi-center clinical data aggregation for percutaneous ablation procedures, used internally and with clinical partners to generate evidence on robotic-assisted ablation outcomes and to support regulatory and clinical publications.
Quantifiable outcome
- Over 1,700 patients treated worldwide with Epione robotic platform
- +4 more outcomes
Companies that use Quantum Surgical
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles1 record
Quantum Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Quantum Surgical partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, minor and major.
- Precision IO Group Inc.coreNewly created parent company combining Quantum Surgical and NeuWave Medical as subsidiaries. Led by medtech veteran Kurt Azarbarzin as CEO. Backed by investment from Ally Bridge Group. The group's ambition is to become a leader in interventional radiology with focus on precision and remote procedures.
- NeuWave Medical, Inc.coreAcquired from Johnson & Johnson, NeuWave is a medical device company with microwave ablation technology used in 70% of top US cancer centers. Now operates as subsidiary of Precision IO Group alongside Quantum Surgical. Acquisition combines Epione robotic platform with NeuWave's market-leading ablation technology.
- StifelminorServed as exclusive financial advisor to Quantum Surgical for the NeuWave Medical acquisition.
- McDermott Will & Schulte LLPminorLegal advisor to Quantum Surgical for the NeuWave Medical acquisition transaction.
- PreciseOnco ConsortiummajorEU-funded research consortium (€14.9M IHI grant, €23.9M total budget) coordinated by Philips. Quantum Surgical participates alongside Philips, IGEA, research institutes, and European hospitals to advance precision cancer treatment through spectral imaging, robotic guidance, and AI technologies over a five-year program.
- PhilipsmajorCoordinator of PreciseOnco research consortium. Leading medical technology company partnering on spectral imaging and AI-guided integrated technologies for precision cancer care.
- IGEAminorIndustry partner in PreciseOnco consortium contributing to precision cancer treatment technologies including electrochemotherapy.
- Unison Healthcare GroupmajorTaiwanese distributor partnership for Epione commercialization. Unison Healthcare Group distributes multiple surgical robots in Taiwan and has B Corp certification. Partnership extends Quantum Surgical's presence in Taiwan market.
- Scientific Advisory Board MembersmajorInternational experts in interventional oncology providing clinical guidance and support: Dr. Govindarajan Narayanan (Baptist Health), Dr. Steven D. Colquhoun (Wellstar MCG Health), Dr. Thierry De Baère (Gustave Roussy), Dr. Laurent Milot (Hospices Civils de Lyon), Dr. Luigi Solbiati (Humanitas University), Dr. Sean Tutton (UC San Diego).
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Quantum Surgical competitors and assessment
Company assessmentBroad incumbents
- Intuitive Surgical: Dominant surgical robotics incumbent (da Vinci platform) with extensive global hospital footprint and strong KOL relationships. While focused on laparoscopic surgery, Intuitive's installed base and R&D capacity make it a long-term competitive threat as interventional oncology robotics expands.
- Boston Scientific: Major medtech company with significant interventional oncology and percutaneous ablation portfolio (formerly including the NeuWave microwave ablation business before divesting). Competes broadly in the same hospital call points and could re-enter robotic ablation guidance.
- Stryker: Owns the MAKO surgical robotics platform and acquired Mobius Imaging/Cardan Robotics for image-guided interventional capabilities. Comparable as a surgical robotics incumbent expanding into image-guided and interventional procedures.
- Medtronic: Owner of the Hugo robotic-assisted surgery platform and Mazor spine robotics. As a broad medtech incumbent pushing into surgical robotics and interventional procedures, Medtronic competes for hospital capital equipment budgets and interventional radiology share of mind.
- Johnson & Johnson MedTech: Owner of MONARCH robotic bronchoscopy platform (Auris Health) and previous owner of NeuWave (divested to Quantum Surgical in Feb 2026). Highly comparable as the seller of one of Quantum Surgical's core acquired assets and as an adjacent robotic interventional oncology competitor.
Direct peers
- AngioDynamics: Pure-play interventional oncology and vascular device company offering microwave and radiofrequency ablation systems, including the Solero and Acculis platforms. Directly comparable as a tumor ablation capital equipment vendor serving interventional radiology departments.
- Merit Medical Systems: Interventional radiology and oncology device company offering ablation systems, microcatheters, and embolization products. Comparable as a direct supplier of percutaneous tumor ablation capital equipment and consumables to interventional radiology departments.
Emerging players
- Siemens Healthineers (Corindus): Acquired Corindus, a robotic-assisted vascular intervention platform. Comparable as a robotic guidance system for image-guided minimally invasive procedures, though currently focused on vascular rather than oncology applications.
- Profound Medical: Developer of the TULSA-PRO robotic transurethral ultrasound ablation system for prostate tissue, plus Sonalleve MR-HIFU platform. Comparable as a focused image-guided ablation robotics company targeting oncology indications with novel energy modalities.
- EDAP TMS: Focused ablation device company with Focal One high-intensity focused ultrasound (HIFU) robotic platform for prostate cancer and ExactVu micro-ultrasound. Comparable as a specialty robotic ablation company addressing oncology indications in hospital settings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Quantum Surgical social profiles
Digital presenceQuantum Surgical compliance and trust
Trust signalCompliance4 records
Quantum Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quantum Surgical leadership team
Management profileNumber of profiles
Profiles16 records
Quantum Surgical subsidiaries and ownership
Company hierarchySubsidiaries1 record
Quantum Surgical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quantum Surgical M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quantum Surgical
What does Quantum Surgical do?
Quantum Surgical designs, manufactures, and commercializes the Epione robotic-assisted percutaneous ablation platform for interventional radiology. The system combines a robotic arm, image-guided navigation software, and ablation instrument integration to enable interventional radiologists to plan, target, and treat tumors in the abdomen and lungs via minimally invasive needle-based ablation. The company also markets the NeuWave Microwave Ablation System and the HYGIE Health Data Warehouse research infrastructure acquired through its integration into the Precision IO Group.
Is Quantum Surgical a public or private company?
Quantum Surgical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Quantum Surgical founded?
Quantum Surgical was founded in 2017. It employs 101 to 250 people.
Where is Quantum Surgical based?
Quantum Surgical is headquartered in Montpellier, France, in the Europe region.
How does Quantum Surgical make money?
Four revenue lines are on record. Epione Robotic Platform Sales are the primary driver. The others are neuWave Ablation Products, service and Support Contracts and professional Services.
Who are Quantum Surgical's main competitors?
Broad incumbents on record are Intuitive Surgical, Boston Scientific, Stryker, Medtronic and Johnson & Johnson MedTech. Direct peers are AngioDynamics and Merit Medical Systems. Emerging players are Siemens Healthineers (Corindus), Profound Medical and EDAP TMS.
Does Quantum Surgical have an API?
No public API is recorded for Quantum Surgical.
What industry is Quantum Surgical in?
Quantum Surgical's product category is Interventional Oncology / Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.